Arbor Biotechnologies IPO

arbor.bio

Arbor Biotechnologies utilizes AI and machine learning to develop gene editing tools to uncover curative treatments for previously uncurable genetic diseases.

Founded2016
Total Funding to Date$231.6MM
Register for Details

For more details on financing and valuation for Arbor Biotechnologies, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Arbor Biotechnologies Ticker Symbol

Arbor Biotechnologies does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Arbor Biotechnologies Stock Price

The stock price for Arbor Biotechnologies will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Arbor Biotechnologies Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
11/9/2021 Series B $215MM raised $XXX.XX $XXX.XX
5/19/2017 Series A $16.6MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Arbor Biotechnologies in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector